Evaluation of the analytical and clinical characteristics of the siemens immulite®2000 tsi method for determining thyrotropin receptor antibodies
Background: Despite commercially improved, standardised routine methods used in medical laboratories, precision laboratory medicine lacks harmonisation of results to make the laboratory result useful for its intended purpose. Furthermore, to obtain reliable laboratory results and precise diagnoses,...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Medical Biochemists of Serbia, Belgrade
2025-01-01
|
| Series: | Journal of Medical Biochemistry |
| Subjects: | |
| Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582503438M.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849425632057884672 |
|---|---|
| author | Milinković Neda Sarić Marija Ružanović Ana Žarković Miloš Ćirić Jasmina Perović Blagojević Iva Mastilović Ana-Marija Ignjatović Svetlana Nedeljković Beleslin Biljana |
| author_facet | Milinković Neda Sarić Marija Ružanović Ana Žarković Miloš Ćirić Jasmina Perović Blagojević Iva Mastilović Ana-Marija Ignjatović Svetlana Nedeljković Beleslin Biljana |
| author_sort | Milinković Neda |
| collection | DOAJ |
| description | Background: Despite commercially improved, standardised routine methods used in medical laboratories, precision laboratory medicine lacks harmonisation of results to make the laboratory result useful for its intended purpose. Furthermore, to obtain reliable laboratory results and precise diagnoses, it is important and recommended that each laboratory confirms the analytical and clinical characteristics of the method used. This study aimed to evaluate the analytical and clinical performance of the IMMULITE®2000 TSI bridge immunoassay to determine autoreactive thyroid stimulating hormone receptor antibodies (SH-R-Ab). Methods: A total of 86 patients with clinically present Graves' orbitopathy and 23 healthy volunteers as a control group were included in the study. The total TSH-R-Ab concentration was determined using an ECLIA (Elecsys Anti-TSHR Immunoassay Roche Diagnostics, GmbH, Mannheim, Germany) on the Cobas e411 analyser (Roche, Diagnostics, GmbH). The TSH-R-Ab concentration was measured using a CLIA method (IMMULITE TSI 2000, Siemens Healthcare Diagnostics, UK). The inaccuracy of the method was investigated using two levels of commercial control samples (low and high analyte concentration). Results: The results obtained meet the general minimum requirements for the analytical performance of laboratory methods (CV<5%). The overall laboratory inaccuracy was acceptable according to FDA guidelines (CV<20%). The results showed a statistically significant correlation between the analysed methods (r=0.9041, p < 0.0001) but with a relative bias of 24.5%. The best ratio of sensitivity and specificity determined by the ROC analysis (93.3% and 100%, respectively) was obtained for a cut-off value of 0.1215 IU/L, which is significantly lower compared to the cut-off value specified by the manufacturer (0.55 IU/L). Conclusions: The IMMULITE 2000 TSI bridge immunoassay for TSH-R-Ab quantification confirmed adequate precision, which is essential for routine use. However, further studies are required to evaluate its analytical specificity. |
| format | Article |
| id | doaj-art-c5ddcdb3361a470688845dff54695857 |
| institution | Kabale University |
| issn | 1452-8258 1452-8266 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Society of Medical Biochemists of Serbia, Belgrade |
| record_format | Article |
| series | Journal of Medical Biochemistry |
| spelling | doaj-art-c5ddcdb3361a470688845dff546958572025-08-20T03:29:43ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662025-01-0144343844610.5937/jomb0-558731452-82582503438MEvaluation of the analytical and clinical characteristics of the siemens immulite®2000 tsi method for determining thyrotropin receptor antibodiesMilinković Neda0https://orcid.org/0000-0002-2641-9817Sarić Marija1https://orcid.org/0000-0001-7591-8885Ružanović Ana2https://orcid.org/0009-0009-7125-2428Žarković Miloš3https://orcid.org/0000-0001-9977-5970Ćirić Jasmina4Perović Blagojević Iva5https://orcid.org/0000-0001-8418-4238Mastilović Ana-Marija6Ignjatović Svetlana7https://orcid.org/0000-0001-9241-5737Nedeljković Beleslin Biljana8https://orcid.org/0000-0002-1687-9297University of Belgrade, Faculty of Pharmacy, Department of Medical Biochemistry, Belgrade, SerbiaUniversity of Belgrade, Faculty of Pharmacy, Department of Medical Biochemistry, Belgrade, SerbiaUniversity of Belgrade, Faculty of Pharmacy, Department of Medical Biochemistry, Belgrade, SerbiaUniversity Clinical Center of Serbia, Clinic of Endocrinology, Belgrade, Serbia, SerbiaUniversity Clinical Center of Serbia, Clinic of Endocrinology, Belgrade, Serbia, SerbiaClinical Hospital Center "Dr Dragiša Mišović-Dedinje", Service for laboratory diagnostics, Belgrade, SerbiaClinical Hospital Center "Dr Dragiša Mišović-Dedinje", Service for laboratory diagnostics, Belgrade, SerbiaUniversity of Belgrade, Faculty of Pharmacy, Department of Medical Biochemistry, Belgrade, SerbiaUniversity Clinical Center of Serbia, Clinic of Endocrinology, Belgrade, Serbia, SerbiaBackground: Despite commercially improved, standardised routine methods used in medical laboratories, precision laboratory medicine lacks harmonisation of results to make the laboratory result useful for its intended purpose. Furthermore, to obtain reliable laboratory results and precise diagnoses, it is important and recommended that each laboratory confirms the analytical and clinical characteristics of the method used. This study aimed to evaluate the analytical and clinical performance of the IMMULITE®2000 TSI bridge immunoassay to determine autoreactive thyroid stimulating hormone receptor antibodies (SH-R-Ab). Methods: A total of 86 patients with clinically present Graves' orbitopathy and 23 healthy volunteers as a control group were included in the study. The total TSH-R-Ab concentration was determined using an ECLIA (Elecsys Anti-TSHR Immunoassay Roche Diagnostics, GmbH, Mannheim, Germany) on the Cobas e411 analyser (Roche, Diagnostics, GmbH). The TSH-R-Ab concentration was measured using a CLIA method (IMMULITE TSI 2000, Siemens Healthcare Diagnostics, UK). The inaccuracy of the method was investigated using two levels of commercial control samples (low and high analyte concentration). Results: The results obtained meet the general minimum requirements for the analytical performance of laboratory methods (CV<5%). The overall laboratory inaccuracy was acceptable according to FDA guidelines (CV<20%). The results showed a statistically significant correlation between the analysed methods (r=0.9041, p < 0.0001) but with a relative bias of 24.5%. The best ratio of sensitivity and specificity determined by the ROC analysis (93.3% and 100%, respectively) was obtained for a cut-off value of 0.1215 IU/L, which is significantly lower compared to the cut-off value specified by the manufacturer (0.55 IU/L). Conclusions: The IMMULITE 2000 TSI bridge immunoassay for TSH-R-Ab quantification confirmed adequate precision, which is essential for routine use. However, further studies are required to evaluate its analytical specificity.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582503438M.pdfthyroid stimulating hormone receptor antibodiesanalytical and clinical sensitivity and specificity |
| spellingShingle | Milinković Neda Sarić Marija Ružanović Ana Žarković Miloš Ćirić Jasmina Perović Blagojević Iva Mastilović Ana-Marija Ignjatović Svetlana Nedeljković Beleslin Biljana Evaluation of the analytical and clinical characteristics of the siemens immulite®2000 tsi method for determining thyrotropin receptor antibodies Journal of Medical Biochemistry thyroid stimulating hormone receptor antibodies analytical and clinical sensitivity and specificity |
| title | Evaluation of the analytical and clinical characteristics of the siemens immulite®2000 tsi method for determining thyrotropin receptor antibodies |
| title_full | Evaluation of the analytical and clinical characteristics of the siemens immulite®2000 tsi method for determining thyrotropin receptor antibodies |
| title_fullStr | Evaluation of the analytical and clinical characteristics of the siemens immulite®2000 tsi method for determining thyrotropin receptor antibodies |
| title_full_unstemmed | Evaluation of the analytical and clinical characteristics of the siemens immulite®2000 tsi method for determining thyrotropin receptor antibodies |
| title_short | Evaluation of the analytical and clinical characteristics of the siemens immulite®2000 tsi method for determining thyrotropin receptor antibodies |
| title_sort | evaluation of the analytical and clinical characteristics of the siemens immulite r 2000 tsi method for determining thyrotropin receptor antibodies |
| topic | thyroid stimulating hormone receptor antibodies analytical and clinical sensitivity and specificity |
| url | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582503438M.pdf |
| work_keys_str_mv | AT milinkovicneda evaluationoftheanalyticalandclinicalcharacteristicsofthesiemensimmulite2000tsimethodfordeterminingthyrotropinreceptorantibodies AT saricmarija evaluationoftheanalyticalandclinicalcharacteristicsofthesiemensimmulite2000tsimethodfordeterminingthyrotropinreceptorantibodies AT ruzanovicana evaluationoftheanalyticalandclinicalcharacteristicsofthesiemensimmulite2000tsimethodfordeterminingthyrotropinreceptorantibodies AT zarkovicmilos evaluationoftheanalyticalandclinicalcharacteristicsofthesiemensimmulite2000tsimethodfordeterminingthyrotropinreceptorantibodies AT ciricjasmina evaluationoftheanalyticalandclinicalcharacteristicsofthesiemensimmulite2000tsimethodfordeterminingthyrotropinreceptorantibodies AT perovicblagojeviciva evaluationoftheanalyticalandclinicalcharacteristicsofthesiemensimmulite2000tsimethodfordeterminingthyrotropinreceptorantibodies AT mastilovicanamarija evaluationoftheanalyticalandclinicalcharacteristicsofthesiemensimmulite2000tsimethodfordeterminingthyrotropinreceptorantibodies AT ignjatovicsvetlana evaluationoftheanalyticalandclinicalcharacteristicsofthesiemensimmulite2000tsimethodfordeterminingthyrotropinreceptorantibodies AT nedeljkovicbeleslinbiljana evaluationoftheanalyticalandclinicalcharacteristicsofthesiemensimmulite2000tsimethodfordeterminingthyrotropinreceptorantibodies |